acd 9/22/14 joyce johnsrud
DESCRIPTION
Internal MedicineTRANSCRIPT
![Page 1: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/1.jpg)
Joyce Johnsrud, PGY-2
ACD 09.22.14
![Page 2: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/2.jpg)
Case
*~60 yo woman presents in septic shock from pyelonephritis. Initially gets volume resuscitated, abx, and norepinephrine at 10 but doing ok on RA.
![Page 3: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/3.jpg)
Imaging
On admission
![Page 4: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/4.jpg)
*Hospital day 2 develops respiratory distress, so you get a CXR…
![Page 5: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/5.jpg)
Hosp day 2 worsening SOA 7.23/34/53 on RA
HCO3 14; lactate 4.6
![Page 6: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/6.jpg)
*Diagnosis?
*PaO2/FiO2 ratio?
7.23/34/53 on RA
![Page 7: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/7.jpg)
*PaO2/FiO2 ratio?
*53 / 0.21 = 252
*Diagnosis?
* Acute Respiratory Distress Syndrome
![Page 8: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/8.jpg)
HD 2, later that p.m., after diuresis
7.25/45/45 on 5L O2 NC HCO3 19
![Page 9: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/9.jpg)
HD3 interval intubation
HD3 ABG 7.2/47/41 on 32/320/12/100
HD3 prone ABG 7.26/40/135 on 32/300/12/100
HCO3 23; Peak pressure 60
![Page 10: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/10.jpg)
HD5 a.m. CXR
![Page 11: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/11.jpg)
Diagnosis of new findings on this CXR?
HD5 a.m. CXR
![Page 12: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/12.jpg)
Penumomediastinum
![Page 13: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/13.jpg)
09/14
![Page 14: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/14.jpg)
Acute respiratory distress syndrome
![Page 15: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/15.jpg)
Berlin Criteria
*Acute Onset in setting of predisposing condition
*Bilateral infiltrates
*No evidence of left heart failure or fluid overload
*PaO2/FiO2 ≤ 300 mm Hg
*Mild PaO2/FiO2 200 to ≤ 300 mm Hg
*Moderate PaO2/FiO2 100 to ≤ 200 mm Hg
*Severe PaO2/FiO2 ≤ 100 mm Hg
![Page 16: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/16.jpg)
Lung Protective Ventilation in ARDS* Initial VT = 8 mL/kg PBW at PEEP 5 cm H2O, FiO2 to achieve SpO2
88-95%
* Reduce VT by 1 mL/kg every 2 hours until at goal
* Then measure Ppl. If Ppl > 30 cm H2O, decrease VT by 1 mL/kg until at goal or VT = 4 mL/kg
* Respiratory acidosis
* If pH =7.15-7.30, increase RR until pH > 7.30 or RR = 35 bpm
* If pH < 7.15, increase RR to 35 bpm. If pH is still < 7.15, increase VT
by 1 mL/kg until pH > 7.15
* Permissive hypercapnia PaCO2 60-70 mm Hg and pH 7.2-7.25 safe for most patients
*Goals
*VT = 6 mL/kg PBW
*Ppl ≤ 30 cm H2O
*SpO2 = 88-95%
*pH = 7.30-7.45
Decreases Mortality and duration on vent
![Page 17: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/17.jpg)
What about when that doesn’t work?
*Prone positioning
*Inhaled Nitric Oxide
*High Frequency Oscillatory Ventilation
*Extracorporeal membrane oxygenation
![Page 18: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/18.jpg)
What about when that doesn’t work?
*Prone positioning- Physiology* Improves gas exchange, reduces V/Q mismatch
* Pleural pressure
* Supine: overinflation of the ventral alveoli and atelectasis of the dorsal alveoli which is exaggerated ARDS
* Prone: reduction in difference between the dorsal and ventral pleural pressures leading to more homogeneous ventilation
*Compression
* Supine: heart compresses the medial posterior lung and diaphragm compresses the posterior-caudal lung parenchyma worsening dependent lung collapse
* Prone: heart becomes dependent and diaphragm displaced, decreasing medial posterior compression, also improving cardiac output through increases in RV preload, decreased RV afterload due to recruitment and reduction in hypoxic pulmonary vasoconstriction
* Perfusion
![Page 19: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/19.jpg)
Prone positioning*PROSEVA
* Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368:2159.
*Multicenter, prospective, RCT of 466 patients with severe ARDS (PaO2/FiO2 <150 mmHg, FiO2 ≥0.6, PEEP ≥5 cm H2O) on low tidal volume mechanical ventilation
* Prone-positioning sessions of at least 16 hours vs supine Prone Supine
28-day mortality: 16% vs 33% [HR 0.39, 95% CI 0.25-0.63; p <0.001]
90-day mortality: 24% vs 41% [HR 0.44, 95% CI 0.29-0.67; p <0.001]
Ventilator Free days/28 days: 14 days
vs 10 days [p<0.001]
Successful extubation at 90 days: 81%
vs 65% [HR 0.45, 95% CI 0.29-0.70; p<0.001]
Pneumothorax: 6.3% vs 5.7% [HR 0.89, 95% CI 0.39-2.02]
Outcome:
![Page 20: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/20.jpg)
Prone positioning*Limitations:
*1434 patients screened, 858 not eligible based on exclusion criteria
*Exclusion criteria lengthy
![Page 21: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/21.jpg)
Prone positioning
•Use of NIV inhaled nitric oxide or almitrine bismesylate, or extracorporeal membrane oxygenation (ECMO) before inclusion.
![Page 22: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/22.jpg)
Prone positioning*Limitations:
*1434 patients screened, 858 not eligible based on exclusion criteria
*Exclusion criteria lengthy
*Despite randomization, patients in supine group had higher SOFA scores, required more pressors and NM blocking agents
*Study site staff had extensive experience with prone ventilation
*Labor intensive, nutritional and nursing challenges
*Suggests mortality benefit of early, high-dose prone ventilation in a select population of severe ARDS who fail to improve with standard-of-care supine low tidal volume ventilation strategies when applied early after intubation but needs further validation
![Page 23: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/23.jpg)
Inhaled Nitric Oxide
*Selective pulmonary vasodilator
*Increase flow to areas of high dead space ventilation
*Increase in arterial oxygenation is temporary- 1 to 4 days
*No assoc’d mortality benefit
*Adverse effects:
*Methemoglobinemia- rare
*Renal dysfunction (relative risk 1.59, 95% CI 1.17 to 2.16)
*Reserved for use in refractory hypoxemia
![Page 24: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/24.jpg)
Supportive Care
*Sedation with daily wake up protocol
*Oral care
*Nutrition
*Elevated HOB
*DVT ppx
*GI ppx
![Page 25: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/25.jpg)
Supportive Care*Fluid balance* Wiedemann, HP et al. Comparison of two fluid-management strategies in
acute lung injury. N Engl J Med. 2006;354(24):2564. NHLBI ARDS Clinical Trials Network
Conservative group Liberal group
Targeted CVP <4 mmHg or a pulmonary artery occlusion pressure (PAOP) <8 mmHg
Targeted CVP of 10 to 14 mmHg or a PAOP of 14 to 18 mmHg
Mean cumulative fluid balance was -136 mL
Mean cumulative fluid balance was +6992 mL
Ventilator free days 15 days
vs 12 days
ICU free days 13 days vs 11 days
60 day mortality rate unchanged
![Page 26: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/26.jpg)
Supportive Care*Steroid therapy
*Early severe ARDS PaO2/FiO2 < 200 mm Hg on PEEP 5
* IV methylprednisolone 1 mg/kg/day x14 days; taper over next 14 days and discontinue
*Fibrinoproliferative phase of ARDS
* Risk of irreversible pulmonary fibrosis
*Occurs 7-14 days after onset
* IV methylprednisolone 2 mg/kg/day x14 days; 1 mg/kg/day x7 days; taper and discontinue at 2 wks post-extubation
*Risk of worsening glycemic control and prolonged neuromuscular weakness
![Page 27: Acd 9/22/14 Joyce Johnsrud](https://reader038.vdocument.in/reader038/viewer/2022103115/556dbaa8d8b42aed2e8b4a95/html5/thumbnails/27.jpg)
References
*Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368:2159.
*Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354(24):2564.
*ARDS Network www.ardsnet.org
*uptodate.com
*Marino, Paul L. The ICU Book: Fourth Edition. New York: Lippincott, 2014.